A share price of Aldeyra Therapeutics Inc [ALDX] is currently trading at $3.27, up 6.17%. An important factor to consider is whether the stock is rising or falling in short-term value. The ALDX shares have gain 12.37% over the last week, with a monthly amount drifted -11.38%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, H.C. Wainwright started tracking the stock with Buy rating on February 08, 2021, and set its price target to $26. On December 16, 2020, Berenberg initiated with a Buy rating and assigned a price target of $32 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $24 on October 30, 2020. BTIG Research initiated its recommendation with a Buy and recommended $29 as its price target on October 16, 2020. Alliance Global Partners started tracking with a Buy rating for this stock on September 22, 2020, and assigned it a price target of $32. In a note dated May 12, 2020, Oppenheimer initiated an Outperform rating and provided a target price of $12 on this stock.
Aldeyra Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $1.42 and $11.97. Aldeyra Therapeutics Inc [NASDAQ: ALDX] shares were valued at $3.27 at the most recent close of the market.
Analyzing the ALDX fundamentals
Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -109.0%, Pretax Profit Margin comes in at -95.62%, and Net Profit Margin reading is -93.85%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.29 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.09 points at the first support level, and at 2.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.47, and for the 2nd resistance point, it is at 3.68.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aldeyra Therapeutics Inc [NASDAQ:ALDX] is 6.44. On the other hand, the Quick Ratio is 6.44, and the Cash Ratio is 6.42.
Transactions by insiders
Recent insider trading involved Brady Todd C, President and CEO, that happened on Mar 12 ’24 when 85324.0 shares were sold. Chief Development Officer, Machatha Stephen completed a deal on Mar 12 ’24 to sell 11537.0 shares. Meanwhile, President and CEO Brady Todd C sold 97914.0 shares on Mar 11 ’24.
